Association of high pulse pressure with proteinuria in subjects with diabetes, prediabetes, or normal glucose tolerance in a large Japanese general population sample

Diabetes Care

Volumn 35, Issue 6, 2012, Pages 1310-1315

  Yano, Yuichiro ^a   Sato, Yuji ^b   Fujimoto, Shouichi ^c   Konta, Tsuneo ^d   Iseki, Kunitoshi ^e   Moriyama, Toshiki ^e   Yamagata, Kunihiro ^e   Tsuruya, Kazuhiko ^e   Yoshida, Hideaki ^e   Asahi, Koichi ^e   Kurahashi, Issei ^f   Ohashi, Yasuo ^f   Watanabe, Tsuyoshi ^e  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c UNIVERSITY OF MIYAZAKI HOSPITAL   (Japan)

^d YAMAGATA UNIVERSITY   (Japan)

^e Steering Comm for the Res on the Positioning of CKD in Specific Hlth Check and Guid in Japan   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE TOLERANCE; HIGH PULSE PRESSURE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; JAPANESE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEINURIA; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINE DIPSTICK TEST;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; JAPAN; MALE; MIDDLE AGED; PREDIABETIC STATE; PREVALENCE; PROTEINURIA; QUESTIONNAIRES; RISK FACTORS; VASCULAR RESISTANCE;

EID: 84861719598     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2245     Document Type: Article

References (37)

1. Loutzenhiser R, Bidani A, Chilton L. Renal myogenic response: kinetic attributes and physiological role. Circ Res 2002;90:1316-1324 (Pubitemid 34787414)
2. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005;46:200-204 (Pubitemid 40946514)
3. Ito S, Nagasawa T, Abe M, Mori T. Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res 2009;32:115-121
4. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982;72:375-380 (Pubitemid 12188669)
5. Anderson S. Relevance of single nephron studies to human glomerular function. Kidney Int 1994;45:384-389 (Pubitemid 24065070)
6. Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 2008;51:714-725
7. Pedrinelli R, Dell'Omo G, Penno G, et al. Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men. Hypertension 2000;35:48-54 (Pubitemid 30054236)
8. Cirillo M, Stellato D, Laurenzi M, Panarelli W, Zanchetti A, De Santo NG; The GUBBIO Study Collaborative Research Group. Pulse pressure and isolated systolic hypertension: association with microalbuminuria. Kidney Int 2000;58:1211-1218
9. Farasat SM, Valdes C, Shetty V, et al. Is longitudinal pulse pressure a better predictor of 24-hour urinary albumin excretion than other indices of blood pressure? Hypertension 2010;55:415-421
10. Tsakiris A, Doumas M, Lagatouras D, et al. Microalbuminuria is determined by systolic and pulse pressure over a 12-year period and related to peripheral artery disease in normotensive and hypertensive subjects: the Three Areas Study in Greece (TAS-GR). Angiology 2006;57:313-320 (Pubitemid 44438551)
11. Parving HH, Kastrup H, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1984;27:547-552 (Pubitemid 15178762)
12. Christensen PK, Hansen HP, Parving HH. Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients. Kidney Int 1997;52:1369-1374 (Pubitemid 27496067)
13. Carmines PK. The renal vascular response to diabetes. Curr Opin Nephrol Hypertens 2010;19:85-90
14. Knudsen ST, Poulsen PL, Hansen KW, Ebbehøj E, Bek T, Mogensen CE. Pulse pressure and diurnal blood pressure variation: association with micro- and macrovascular complications in type 2 diabetes. Am J Hypertens 2002;15:244-250 (Pubitemid 34226190)
15. Palmas W, Moran A, Pickering T, et al. Ambulatory pulse pressure and progression of urinary albumin excretion in older patients with type 2 diabetes mellitus. Hypertension 2006;48:301-308 (Pubitemid 44309827)
16. Knudsen ST, Laugesen E, Hansen KW, Bek T, Mogensen CE, Poulsen PL. Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patients. Diabetologia 2009;52:698-704
17. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-S69
18. DeFronzo RA, Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am J Cardiol 2011;108(Suppl. 3):3B-24B
19. Yano Y, Fujimoto S, Sato Y, et al. Association between prehypertension and chronic kidney disease in the Japanese general population. Kidney Int 2012;81:293-299
20. The Committee of Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Japan Diab Soc 2010;53:450-467
21. Matsuo S, Imai E, Horio M, et al.; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-992
22. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care 2010;33(Suppl. 1):S11-S61
23. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003;63:1468-1474 (Pubitemid 36350012)
24. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011;80:17-28
25. de Zeeuw D, Raz I. Albuminuria: a great risk marker, but an underestimated target in diabetes. Diabetes Care 2008;31(Suppl. 2):S190-S193
26. de Jong PE, van der Velde M, Gansevoort RT, Zoccali C. Screening for chronic kidney disease: where does Europe go? Clin J Am Soc Nephrol 2008;3:616-623
27. Benetos A, Waeber B, Izzo J, et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 2002;15:1101-1108 (Pubitemid 35397546)
28. Schram MT, Kostense PJ, Van Dijk RA, et al. Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study. J Hypertens 2002;20:1743-1751
29. Dart AM, Kingwell BA. Pulse pressure - a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001;37:975-984 (Pubitemid 32217593)
30. Ford ML, Tomlinson LA, Chapman TP, Rajkumar C, Holt SG. Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension 2010;55:1110-1115
31. Briet M, Collin C, Karras A, et al.; Nephrotest Study Group. Arterial remodeling associates with CKD progression. J Am Soc Nephrol 2011;22:967-974
32. Bouchi R, Babazono T, Mugishima M, et al. Arterial stiffness is associated with incident albuminuria and decreased glomerular filtration rate in type 2 diabetic patients. Diabetes Care 2011;34:2570-2575
33. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-2140
34. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011;34:1249-1257
35. Heianza Y, Hara S, Arase Y, et al. HbA1c 5z7-6z4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet 2011;378:147-155
36. Neville SE, Boye KS, Montgomery WS, Iwamoto K, Okamura M, Hayes RP. Diabetes in Japan: a review of disease burden and approaches to treatment. Diabetes Metab Res Rev 2009;25:705-716
37. Paulis L, Unger T. Novel therapeutic targets for hypertension. Nat Rev Cardiol 2010;7:431-441